Who Owns LIXTW?

LIXTE BIOTECHNOLOGY HLDGS IN — Institutional Ownership & 13F Holdings

$0.00

+0.00 (+0.00%)

Market Cap

Shares Outstanding

Institutional Holders

3

Total Inst. Value

$2K

% of Float Held

QoQ Holder Change

-2

Institutional data as of Q1 2025

New Positions

3

Closed Positions

0

Increased

0

Decreased

0

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1CITADEL ADVISORS LLCNew$88026,032
2CLEAR STREET LLCNew$76622,654
3BANK OF AMERICA CORP /DE/New$0100

Biggest Buyers & Sellers This Quarter

Top Buyers

FundShares AddedValue
CITADEL ADVISORS LLCNew+26K$880
CLEAR STREET LLCNew+23K$766
BANK OF AMERICA CORP /DE/New+100$0

Top Sellers

FundShares RemovedValue

Frequently Asked Questions

How many institutional investors hold LIXTW?

As of Q1 2025, 3 institutional investors report holding LIXTW (LIXTE BIOTECHNOLOGY HLDGS IN) in their 13F filings.

Which hedge fund owns the most LIXTW?

The largest institutional holder of LIXTW is CITADEL ADVISORS LLC with $880 in shares.

Are institutions buying or selling LIXTW?

This quarter, 3 institutions opened new positions in LIXTW and 0 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.